Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

Sarah Fordham(Newcastle University), James M. Allan(University of York)
Blood Advances
May 22, 2018
Cited by 46


Related Papers